Ischemic epigenetics and the transplanted kidney (Q38306439)

2 September 2017

title

Ischemic epigenetics and the transplanted kidney (English)

1 reference

2 September 2017

1 reference

Pratt JR

1

1 reference

2 September 2017

Parker MD

2

1 reference

2 September 2017

Affleck LJ

3

1 reference

2 September 2017

Corps C

4

1 reference

2 September 2017

Hostert L

5

1 reference

2 September 2017

Michalak E

6

1 reference

2 September 2017

Lodge JP

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Transplantation Proceedings

2 September 2017

published in

1 reference

2 September 2017

volume

38

1 reference

2 September 2017

issue

10

1 reference

2 September 2017

page(s)

3344-3346

1 reference

Delayed graft function in kidney transplantation

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Prognostic significance of free radicals: mediated injury occurring in the kidney donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Acute tubular necrosis is characterized by activation of the alternative pathway of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

In situ localization of C3 synthesis in experimental acute renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Local synthesis of complement component C3 regulates acute renal transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

The role of DNA methylation in mammalian epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Aberrant methylations in cancer cells: where do they come from?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

High sensitivity mapping of methylated cytosines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

MethPrimer: designing primers for methylation PCRs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.10.112

10.1016/J.TRANSPROCEED.2006.10.112

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference